CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net income (loss)	$ (36,696)	$ (836)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	11,751	9,704
Stock-based compensation expense	35,116	33,244
Loss (income) from equity method investments	(15,639)	(9,848)
Distributions of earnings from equity method investments	3,340	0
(Gain) loss on sale of assets, net and impairments	3,784	0
Other noncash items	(837)	(2,322)
Changes in operating assets and liabilities:	(67,312)	(111,957)
Net cash provided by (used in) operating activities	(66,493)	(82,015)
Cash flows from investing activities:
Purchase of property and equipment	(6,451)	(7,811)
Purchase of intangible assets	(17,893)	(1,837)
Investment in loans receivable and other	(9,742)	(8,468)
Investments in marketable securities	(12,006)	(65,568)
Proceeds from maturities of marketable securities and other	115,747	97,269
Net cash paid in business combination	0	(44,367)
Net cash provided by (used in) investing activities	69,655	(30,782)
Cash flows from financing activities:
Proceeds from equity issuances, net	1,345	8,802
Common stock repurchase	0	(200,000)
Repayments of long-term debt	(2,500)	(2,500)
Net cash provided by (used in) financing activities	(1,155)	(193,698)
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents	2,007	(306,495)
Cash, cash equivalents and restricted cash and equivalents from continuing operations, beginning of period	114,329	475,912
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, beginning of period	0	31,768
Cash, cash equivalents and restricted cash and equivalents, beginning of period	114,329	507,680
Cash, cash equivalents and restricted cash and equivalents from continuing operations, end of period	116,336	184,550
Cash, cash equivalents and restricted cash and equivalents from discontinued operations, end of period	0	16,635
Cash, cash equivalents and restricted cash and equivalents, end of period	$ 116,336	$ 201,185